{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:11:01Z","timestamp":1794265861475,"version":"4.9.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021-ZZ-001"],"award-info":[{"award-number":["2021-ZZ-001"]}],"id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002888","name":"Beijing Municipal Commission of Education","doi-asserted-by":"publisher","award":["TJSH20161002502"],"award-info":[{"award-number":["TJSH20161002502"]}],"id":[{"id":"10.13039\/501100002888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771398"],"award-info":[{"award-number":["81771398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Immune-mediated cerebellar ataxias (IMCAs) are common in paraneoplastic cerebellar degeneration (PCD) but rarely occur in patients with neuronal surface antibodies (NSAbs). Although cerebellar ataxias (CAs) associated with anti-NMDAR and anti-CASPR2 have been reported in a few cases, they have never been studied systematically. This study aimed to analyze the characteristics of anti-NSAbs-associated CAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective investigation was conducted to identify patients using the keywords <jats:italic>IMCAs<\/jats:italic> and <jats:italic>NSAbs<\/jats:italic>. We collected the clinical data of 14 patients diagnosed with anti-NSAbs-associated CAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median age was 33 years (16-66), and the male-to-female ratio was 4:3. Nine were positive for NMDAR-Ab, two for LGI1-Ab, two for CASPR2-Ab, and one for AMPA2R-Ab. CAs were initial symptoms in three patients and presented during the first two months of the disease course (10 days on average) among the rest of the patients. After the immunotherapy, two cases were free from symptoms, and eight cases recovered satisfactorily (10\/14, 71.4%). Compared with other causes of IMCAs, anti-NSAbs were more frequently associated with additional extra-cerebellar symptoms (85.7%), mostly seizures (78.6%) and mental abnormalities (64.3%). In the CSF analysis, pleocytosis was detected in ten patients (71.4%) and oligoclonal bands (OB) were observed in nine patients (64.3%). Moreover, compared with PCD and anti-GAD65-Ab-associated CAs, anti-NSAbs-associated CAs showed a better response to immunotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IMCAs are rare and atypical in autoimmune encephalitis with neuronal surface antibodies. Compared with other forms of IMCAs, more symptoms of encephalopathy, a higher rate of pleocytosis and positive OB in CSF, and positive therapeutic effect were the key features of anti-NSAbs-associated CAs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.813926","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T04:42:48Z","timestamp":1645072968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Immune-Mediated Cerebellar Ataxia Associated With Neuronal Surface Antibodies"],"prefix":"10.3389","volume":"13","author":[{"given":"Yu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated With Ovarian Teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21589","article-title":"AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 Potassium Channel-Complex Proteins Leucine-Rich, Glioma Inactivated 1 Protein and Contactin-Associated Protein-2 in Limbic Encephalitis, Morvan's Syndrome and Acquired Neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the Antigen in Limbic Encephalitis Previously Attributed to Potassium Channels: A Case Series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) Receptor in Limbic Encephalitis With Seizures: Case Series and Characterisation of the Antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24117","article-title":"Overlapping Demyelinating Syndromes and Anti\u2013N-Methyl-D-Aspartate Receptor Encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-Associated Protein-2 Antibodies in Non-Paraneoplastic Cerebellar Ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.12.006","article-title":"GABAB Receptor Antibodies in Paraneoplastic Cerebellar Ataxia","volume":"256","author":"Jarius","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","article-title":"Immune-Mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges","volume":"17","author":"Mitoma","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and Prognostic Factors for Long-Term Outcome in Patients With Anti-NMDA Receptor Encephalitis: An Observational Cohort Study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0232","article-title":"Association of Progressive Cerebellar Atrophy With Long-Term Outcome in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis","volume":"73","author":"Iizuka","year":"2016","journal-title":"JAMA Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic Review of the Clinical Spectrum of CASPR2 Antibody Syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A Clinical Approach to Diagnosis of Autoimmune Encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02611","article-title":"Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study","volume":"10","author":"Gu","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-51892-7.00011-5","article-title":"Immune-Mediated Acquired Ataxias","volume":"103","author":"Hadjivassiliou","year":"2012","journal-title":"Handb Clin Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","article-title":"'Medusa-Head Ataxia': The Expanding Spectrum of Purkinje Cell Antibodies in Autoimmune Cerebellar Ataxia. Part 1: Anti-Mglur1, Anti-Homer-3, Anti-Sj\/ITPR1 and Anti-CARP VIII","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","article-title":"'Medusa Head Ataxia': The Expanding Spectrum of Purkinje Cell Antibodies in Autoimmune Cerebellar Ataxia. Part 3: Anti-Yo\/CDR2, Anti-Nb\/AP3B2, PCA-2, Anti-Tr\/DNER, Other Antibodies, Diagnostic Pitfalls, Summary and Outlook","volume":"12","author":"Jarius","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","article-title":"Guidelines for Treatment of Immune-Mediated Cerebellar Ataxias","volume":"2","author":"Mitoma","year":"2015","journal-title":"Cerebellum Ataxias"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000515592","article-title":"The Peculiar Clinical Symptoms and Treatment of Limbic Encephalitis Associated With AMPA Receptor Antibody","volume":"84","author":"Jia","year":"2021","journal-title":"Eur Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1212\/NXI.0000000000000579","article-title":"Cerebellar Ataxia as a Presenting Symptom in a Patient With Anti-NMDA Receptor Encephalitis","volume":"6","author":"Poorthuis","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000342217","article-title":"Hashimoto's Encephalopathy as a Treatable Adult-Onset Cerebellar Ataxia Mimicking Spinocerebellar Degeneration","volume":"69","author":"Matsunaga","year":"2013","journal-title":"Eur Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.093005","article-title":"Hashimoto's Encephalopathy Presenting With Progressive Cerebellar Ataxia","volume":"78","author":"Nakagawa","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577515","article-title":"Anti-Contactin-Associated Protein-Like 2 Antibody-Associated Cerebellar Ataxia: A Case Report and Literature Review","volume":"353","author":"Wang","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/3315","article-title":"Tumor-Specific Killer Cells in Paraneoplastic Cerebellar Degeneration","volume":"4","author":"Albert","year":"1998","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2008.01138.x","article-title":"Morphological and Immunohistochemical Characterization of Paraneoplastic Cerebellar Degeneration Associated With Yo Antibodies","volume":"120","author":"Storstein","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/14734220510007996","article-title":"Modulation of NMDA Receptors in the Cerebellum. 1. Properties of the NMDA Receptor That Modulate Its Function","volume":"4","author":"Llansola","year":"2005","journal-title":"Cerebellum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T04:42:52Z","timestamp":1645072972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2022.813926"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.813926","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"article-number":"813926"}}